Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. en.wikipedia.org › wiki › Zhu_ShizhenZhu Shizhen - Wikipedia

    Zhu Shizhen (Chinese: 朱世珍; pinyin: Zhū Shìzhēn; 1281–1344), born Zhu Wusi (Chinese: 朱五四; pinyin: Zhū Wǔsì), was the father of Zhu Yuanzhang, the founding emperor of the Ming dynasty. He was a native of Jurong (present-day Jurong, Jiangsu). The ancestors of the Zhu family had lived in Pei and later moved to

  2. Shizhen (Jane) Zhu, M.D., Ph.D. is a biomedical researcher who is particularly motivated by work that has the potential to improve public health by advancing the understanding of cancer for the eventual development of improved therapeutics. Dr. Zhu's laboratory utilizes a functional genomics approach and a robust zebrafish model system to ...

  3. 21 de nov. de 2023 · SUMMARY. Shizhen (Jane) Zhu, M.D., Ph.D., is a biomedical researcher who is particularly motivated by work that has the potential to improve public health by advancing the understanding of cancer for the eventual development of improved therapeutics.

  4. Principal Investigator. Shizhen (Jane) Zhu, M.D., Ph.D. Research Fellows and Scientists. Kok Siong Yeo, Ph.D. Josephine M. Lawrence, D.V.M. Daniel Kim, B.S. Sydney Schroeder, B.S. Alexis M. Sosic, B.S. Ke En Tan, B.S., Ph.D. Candidate.

  5. Mayo Clinic. Associate Professor at Mayo Clinic · Experience: Mayo Clinic · Location: Rochester. View Shizhen Zhu’s profile on LinkedIn, a professional community of 1 billion members.

    • Associate Professor at Mayo Clinic
    • Rochester, Minnesota, United States
    • Mayo Clinic
  6. 11 de sept. de 2017 · 1 Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Mayo Clinic Cancer Center, Rochester, MN 55902, USA. Electronic address: zhu.shizhen@mayo.edu. 2 Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Mayo Clinic Cancer Center, Rochester, MN 55902, USA.

  7. Shizhen Zhu's 49 research works with 1,255 citations and 3,680 reads, including: Multiorgan locked-state model of chronic diseases and systems pharmacology opportunities